Truist Securities Reiterates Buy on Encompass Health, Raises Price Target to $156

Benzinga · 1d ago
Truist Securities analyst David Macdonald reiterates Encompass Health (NYSE:EHC) with a Buy and raises the price target from $150 to $156.